Table 1.
Baseline characteristics of patients (n = 113)
| n (%) | Median (range) | |
|---|---|---|
| Age, y | 59 (29-66) | |
| Albumin, g/L | 42.3 (31.8-55.5) | |
| β2-microglobulin, mg/L | 2.9 (1.2-20.6) | |
| ISS I | 65 (58)* | |
| ISS II | 30 (27)* | |
| ISS III | 18 (16)* | |
| uIFE positive | 113 (100) | |
| κ | 72 (64) | |
| λ | 41 (36) | |
| UPEP positive | 87 (78)† | 1 350 (10-11 400)‡ |
| UPEP ≥200 mg per 24 h | 71 (64)† | |
| sFLC ratio abnormal | 113 (100) | |
| κ | 72 (64) | 400.6 (8.3-11 292) |
| λ | 41 (36) | 0.002 (0.0002-0.066) |
| iFLC, mg/L | 1 890 (111-27 400) | |
| iFLC ≥100 mg/L | 113 (100) | |
| Follow up, y | 3.4 (0.4-4.6) |
ISS, International Staging System.
*
Percentage totaling 101% due to rounding up.
†
Two patients missing data.
‡
Milligrams per 24 hours.